LV10396A - Jaunas kontrastvielas - Google Patents

Jaunas kontrastvielas

Info

Publication number
LV10396A
LV10396A LV930171A LV930171A LV10396A LV 10396 A LV10396 A LV 10396A LV 930171 A LV930171 A LV 930171A LV 930171 A LV930171 A LV 930171A LV 10396 A LV10396 A LV 10396A
Authority
LV
Latvia
Prior art keywords
pct
contrast agents
sec
carbon
gas
Prior art date
Application number
LV930171A
Other languages
English (en)
Other versions
LV10396B (en
Inventor
Jo Klaveness
Keith Redford
Pal Rongved
Jan Solberg
Per Strande
Nordby Wiggen
Original Assignee
Nycomed Imaging As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB929204920A external-priority patent/GB9204920D0/en
Priority claimed from GB929204918A external-priority patent/GB9204918D0/en
Application filed by Nycomed Imaging As filed Critical Nycomed Imaging As
Publication of LV10396A publication Critical patent/LV10396A/lv
Publication of LV10396B publication Critical patent/LV10396B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/18—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes
    • A61K49/1818—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles
    • A61K49/1821—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/22—Echographic preparations; Ultrasound imaging preparations ; Optoacoustic imaging preparations
    • A61K49/222—Echographic preparations; Ultrasound imaging preparations ; Optoacoustic imaging preparations characterised by a special physical form, e.g. emulsions, liposomes
    • A61K49/223—Microbubbles, hollow microspheres, free gas bubbles, gas microspheres

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nanotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Physics & Mathematics (AREA)
  • Acoustics & Sound (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Polyesters Or Polycarbonates (AREA)
LVP-93-171A 1992-03-06 1993-03-05 Novel contrast agents LV10396B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB929204920A GB9204920D0 (en) 1992-03-06 1992-03-06 Improvements in or relating to contrast agents
GB929204918A GB9204918D0 (en) 1992-03-06 1992-03-06 Chemical compounds

Publications (2)

Publication Number Publication Date
LV10396A true LV10396A (lv) 1995-02-20
LV10396B LV10396B (en) 1996-02-20

Family

ID=26300446

Family Applications (1)

Application Number Title Priority Date Filing Date
LVP-93-171A LV10396B (en) 1992-03-06 1993-03-05 Novel contrast agents

Country Status (25)

Country Link
US (1) US5795562A (lv)
EP (1) EP0627942B1 (lv)
JP (1) JP3650393B2 (lv)
CN (1) CN1084410A (lv)
AT (1) ATE184491T1 (lv)
AU (1) AU676467B2 (lv)
BG (1) BG99072A (lv)
BR (1) BR9306044A (lv)
CA (1) CA2130670A1 (lv)
CZ (1) CZ284844B6 (lv)
DE (1) DE69326447T2 (lv)
EE (1) EE03079B1 (lv)
ES (1) ES2135466T3 (lv)
FI (1) FI944077A (lv)
HU (1) HUT68612A (lv)
IL (1) IL104963A (lv)
LV (1) LV10396B (lv)
NO (1) NO943272D0 (lv)
NZ (1) NZ249548A (lv)
OA (1) OA10096A (lv)
PL (1) PL174114B1 (lv)
RU (1) RU2122432C1 (lv)
SG (1) SG44668A1 (lv)
SK (1) SK106694A3 (lv)
WO (1) WO1993017718A1 (lv)

Families Citing this family (77)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5922304A (en) * 1989-12-22 1999-07-13 Imarx Pharmaceutical Corp. Gaseous precursor filled microspheres as magnetic resonance imaging contrast agents
IN172208B (lv) 1990-04-02 1993-05-01 Sint Sa
USRE39146E1 (en) 1990-04-02 2006-06-27 Bracco International B.V. Long-lasting aqueous dispersions or suspensions of pressure-resistant gas-filled microvesicles and methods for the preparation thereof
GB9106686D0 (en) * 1991-03-28 1991-05-15 Hafslund Nycomed As Improvements in or relating to contrast agents
US5205290A (en) * 1991-04-05 1993-04-27 Unger Evan C Low density microspheres and their use as contrast agents for computed tomography
MX9205298A (es) * 1991-09-17 1993-05-01 Steven Carl Quay Medios gaseosos de contraste de ultrasonido y metodo para seleccionar gases para usarse como medios de contraste de ultrasonido
US5409688A (en) * 1991-09-17 1995-04-25 Sonus Pharmaceuticals, Inc. Gaseous ultrasound contrast media
US6383470B1 (en) 1992-09-26 2002-05-07 Thomas Fritzsch Microparticle preparations made of biodegradable copolymers
US5558855A (en) * 1993-01-25 1996-09-24 Sonus Pharmaceuticals Phase shift colloids as ultrasound contrast agents
IL108416A (en) 1993-01-25 1998-10-30 Sonus Pharma Inc Colloids with phase difference as contrast ultrasound agents
PL176116B1 (pl) * 1993-01-25 1999-04-30 Sonus Pharma Inc Środek kontrastowy do ultrasonografii i sposób wytwarzania środka kontrastowego do ultrasonografii
GB9305351D0 (en) * 1993-03-16 1993-05-05 Nycomed Imaging As Improvements in or relating to contrast agents
GB9318288D0 (en) * 1993-09-03 1993-10-20 Nycomed Imaging As Improvements in or relating to contrast agents
HU225495B1 (en) 1993-12-15 2007-01-29 Bracco Research Sa Gas mixtures useful as ultrasound contrast media
GB9402867D0 (en) * 1994-02-15 1994-04-06 Nycomed Imaging As Improvements in or relating to contrast agents
GB9417941D0 (en) * 1994-09-06 1994-10-26 Nycomed Imaging As Improvements in or relating to contrast agents
GB9622711D0 (en) * 1996-10-31 1997-01-08 British Tech Group Instrument having enhanced ultrasound visibility
US20020159951A1 (en) * 1997-05-06 2002-10-31 Unger Evan C. Novel targeted compositions for diagnostic and therapeutic use
US7637948B2 (en) 1997-10-10 2009-12-29 Senorx, Inc. Tissue marking implant
US8668737B2 (en) 1997-10-10 2014-03-11 Senorx, Inc. Tissue marking implant
US20010003580A1 (en) 1998-01-14 2001-06-14 Poh K. Hui Preparation of a lipid blend and a phospholipid suspension containing the lipid blend
US6347241B2 (en) 1999-02-02 2002-02-12 Senorx, Inc. Ultrasonic and x-ray detectable biopsy site marker and apparatus for applying it
US8361082B2 (en) 1999-02-02 2013-01-29 Senorx, Inc. Marker delivery device with releasable plug
US8498693B2 (en) 1999-02-02 2013-07-30 Senorx, Inc. Intracorporeal marker and marker delivery device
US9820824B2 (en) 1999-02-02 2017-11-21 Senorx, Inc. Deployment of polysaccharide markers for treating a site within a patent
US7983734B2 (en) 2003-05-23 2011-07-19 Senorx, Inc. Fibrous marker and intracorporeal delivery thereof
US6862470B2 (en) 1999-02-02 2005-03-01 Senorx, Inc. Cavity-filling biopsy site markers
US20090216118A1 (en) 2007-07-26 2009-08-27 Senorx, Inc. Polysaccharide markers
US7651505B2 (en) 2002-06-17 2010-01-26 Senorx, Inc. Plugged tip delivery for marker placement
US6725083B1 (en) 1999-02-02 2004-04-20 Senorx, Inc. Tissue site markers for in VIVO imaging
US6575991B1 (en) 1999-06-17 2003-06-10 Inrad, Inc. Apparatus for the percutaneous marking of a lesion
US7311893B2 (en) * 2000-07-25 2007-12-25 Neurochem (International) Limited Amyloid targeting imaging agents and uses thereof
CA2446993C (en) 2000-11-20 2009-06-02 Senorx, Inc. Tissue site markers for in vivo imaging
GB0128052D0 (en) 2001-11-22 2002-01-16 Drug Discovery Lab As Compounds
AUPR951501A0 (en) * 2001-12-14 2002-01-24 Smart Drug Systems Inc Modified sustained release pharmaceutical system
US7462366B2 (en) 2002-03-29 2008-12-09 Boston Scientific Scimed, Inc. Drug delivery particle
DE10224352A1 (de) * 2002-06-01 2003-12-11 Mueller Schulte Detlef Thermosensitive Polymerträger mit veränderbarer physikalischer Struktur für die biochemische Analytik, Diagnostik und Therapie
AU2003240000A1 (en) 2002-06-12 2003-12-31 Boston Scientific Limited Bulking agents
US7842377B2 (en) 2003-08-08 2010-11-30 Boston Scientific Scimed, Inc. Porous polymeric particle comprising polyvinyl alcohol and having interior to surface porosity-gradient
US8012454B2 (en) 2002-08-30 2011-09-06 Boston Scientific Scimed, Inc. Embolization
US7883490B2 (en) 2002-10-23 2011-02-08 Boston Scientific Scimed, Inc. Mixing and delivery of therapeutic compositions
US20060036158A1 (en) 2003-11-17 2006-02-16 Inrad, Inc. Self-contained, self-piercing, side-expelling marking apparatus
US7877133B2 (en) 2003-05-23 2011-01-25 Senorx, Inc. Marker or filler forming fluid
US7976823B2 (en) 2003-08-29 2011-07-12 Boston Scientific Scimed, Inc. Ferromagnetic particles and methods
US20050273002A1 (en) 2004-06-04 2005-12-08 Goosen Ryan L Multi-mode imaging marker
JP5183068B2 (ja) * 2003-12-22 2013-04-17 フィンレイ，ウォーレン，エイチ 大気噴出凍結乾燥法による粉末形成
US7025726B2 (en) 2004-01-22 2006-04-11 The Regents Of The University Of Nebraska Detection of endothelial dysfunction by ultrasonic imaging
US7736671B2 (en) 2004-03-02 2010-06-15 Boston Scientific Scimed, Inc. Embolization
US8173176B2 (en) 2004-03-30 2012-05-08 Boston Scientific Scimed, Inc. Embolization
US7311861B2 (en) 2004-06-01 2007-12-25 Boston Scientific Scimed, Inc. Embolization
US8425550B2 (en) 2004-12-01 2013-04-23 Boston Scientific Scimed, Inc. Embolic coils
US7858183B2 (en) 2005-03-02 2010-12-28 Boston Scientific Scimed, Inc. Particles
US7727555B2 (en) 2005-03-02 2010-06-01 Boston Scientific Scimed, Inc. Particles
US10357328B2 (en) 2005-04-20 2019-07-23 Bard Peripheral Vascular, Inc. and Bard Shannon Limited Marking device with retractable cannula
US7963287B2 (en) 2005-04-28 2011-06-21 Boston Scientific Scimed, Inc. Tissue-treatment methods
JP2006327986A (ja) * 2005-05-26 2006-12-07 Nitto Denko Corp カーボネート基含有（メタ）アクリル酸エステルモノマーとその製造方法
US8123693B2 (en) 2005-06-20 2012-02-28 Conceptus, Inc. Methods and devices for determining lumen occlusion
US9463426B2 (en) 2005-06-24 2016-10-11 Boston Scientific Scimed, Inc. Methods and systems for coating particles
US8052658B2 (en) 2005-10-07 2011-11-08 Bard Peripheral Vascular, Inc. Drug-eluting tissue marker
US8007509B2 (en) 2005-10-12 2011-08-30 Boston Scientific Scimed, Inc. Coil assemblies, components and methods
US8152839B2 (en) 2005-12-19 2012-04-10 Boston Scientific Scimed, Inc. Embolic coils
US8101197B2 (en) 2005-12-19 2012-01-24 Stryker Corporation Forming coils
US7947368B2 (en) 2005-12-21 2011-05-24 Boston Scientific Scimed, Inc. Block copolymer particles
EP2079385B1 (en) 2006-10-23 2013-11-20 C.R.Bard, Inc. Breast marker
US8414927B2 (en) 2006-11-03 2013-04-09 Boston Scientific Scimed, Inc. Cross-linked polymer particles
US9579077B2 (en) 2006-12-12 2017-02-28 C.R. Bard, Inc. Multiple imaging mode tissue marker
WO2008076973A2 (en) 2006-12-18 2008-06-26 C.R.Bard Inc. Biopsy marker with in situ-generated imaging properties
WO2009099767A2 (en) 2008-01-31 2009-08-13 C.R. Bard, Inc. Biopsy tissue marker
US9327061B2 (en) 2008-09-23 2016-05-03 Senorx, Inc. Porous bioabsorbable implant
EP3005971B1 (en) 2008-12-30 2023-04-26 C. R. Bard, Inc. Marker delivery device for tissue marker placement
US8585616B2 (en) 2009-10-09 2013-11-19 Conceptus, Inc. Methods and apparatus for determining fallopian tube occlusion
USD716451S1 (en) 2013-09-24 2014-10-28 C. R. Bard, Inc. Tissue marker for intracorporeal site identification
USD715442S1 (en) 2013-09-24 2014-10-14 C. R. Bard, Inc. Tissue marker for intracorporeal site identification
USD715942S1 (en) 2013-09-24 2014-10-21 C. R. Bard, Inc. Tissue marker for intracorporeal site identification
USD716450S1 (en) 2013-09-24 2014-10-28 C. R. Bard, Inc. Tissue marker for intracorporeal site identification
CN104817662B (zh) * 2015-04-09 2017-07-14 清华大学 同时用于ct和核磁成像的含碘、含氟氨基磷酸酯类高分子造影剂及其制备方法与应用
JP7115914B2 (ja) 2017-06-23 2022-08-09 住友化学株式会社 レジスト組成物及びレジストパターンの製造方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU636481B2 (en) * 1990-05-18 1993-04-29 Bracco International B.V. Polymeric gas or air filled microballoons usable as suspensions in liquid carriers for ultrasonic echography
PH31064A (en) * 1990-09-07 1998-02-05 Nycomed As Of Nycoveten Polymers containing diester units.
GB9106686D0 (en) * 1991-03-28 1991-05-15 Hafslund Nycomed As Improvements in or relating to contrast agents
GB9106673D0 (en) * 1991-03-28 1991-05-15 Hafslund Nycomed As Improvements in or relating to contrast agents
EP0586524B2 (en) * 1991-06-03 2000-11-02 Nycomed Imaging As Improvements in or relating to contrast agents

Also Published As

Publication number Publication date
CZ214894A3 (en) 1995-04-12
NO943272L (no) 1994-09-05
FI944077A0 (fi) 1994-09-05
CZ284844B6 (cs) 1999-03-17
SG44668A1 (en) 1997-12-19
IL104963A0 (en) 1993-07-08
RU2122432C1 (ru) 1998-11-27
ES2135466T3 (es) 1999-11-01
US5795562A (en) 1998-08-18
AU3642493A (en) 1993-10-05
JP3650393B2 (ja) 2005-05-18
WO1993017718A1 (en) 1993-09-16
IL104963A (en) 1997-09-30
EP0627942A1 (en) 1994-12-14
RU94045927A (ru) 1996-11-10
OA10096A (en) 1996-12-18
HUT68612A (en) 1995-07-28
JPH07505148A (ja) 1995-06-08
EE03079B1 (et) 1998-04-15
FI944077A (fi) 1994-09-05
NO943272D0 (no) 1994-09-05
DE69326447D1 (de) 1999-10-21
LV10396B (en) 1996-02-20
BG99072A (bg) 1995-09-29
SK106694A3 (en) 1995-08-09
HU9402565D0 (en) 1994-11-28
AU676467B2 (en) 1997-03-13
NZ249548A (en) 1996-08-27
PL174114B1 (pl) 1998-06-30
BR9306044A (pt) 1997-11-18
EP0627942B1 (en) 1999-09-15
CN1084410A (zh) 1994-03-30
DE69326447T2 (de) 2000-05-18
CA2130670A1 (en) 1993-09-07
ATE184491T1 (de) 1999-10-15

Similar Documents

Publication Publication Date Title
LV10396A (lv) Jaunas kontrastvielas
MD940199A (ro) Agenţi contrastanţi şi aplicarea acestora
ATE168564T1 (de) Kontrastmittel bestehend aus galaktroseteilchen und einer amphiphilen carbonsaeure
ES2103947T5 (es) Mejoras introducidas en o relacionadas con agentes de contraste.
FI960983A0 (fi) Polymeerisellä pinta-aktiivisella aineella kapseloidut mikrokuplat ja niiden käyttö ultraäänikuvauksessa
DE69328550D1 (de) Verwendung von fulleren-derivaten in diagnostischen und/oder therapeutischen mitteln
DE69412250D1 (de) Pyridobismidazole enthaltendes rigid-rod-Polymer
ES2157460T3 (es) Composicion para el tratamiento de las materias queratinicas que incluye al menos un polimero silicona injertado, de estructura polisiloxanica injertada por monomeros organicos no siliconados y al menos un hidrocarburo.
DK0804152T3 (da) Lactulose-pastiller
GOANsU et al. On Amalgamated Free Products of Residually p-Finite Groups